Loading clinical trials...
Loading clinical trials...
Transcutaneous Electrical Acupoint Stimulation Decreases Remifentanil Consumption and Postoperative Pain in Patients Undergoing Radical Mastectomy: Dual Acupoints Versus Single Acupoint in a Prospective Randomized Controlled Trial
The purpose of this study is to evaluate the effects of transcutaneous electric acupoint stimulation(TEAS) at single acupoint or dual acupoints on opioid consumption and postoperative pain in patients undergoing radical mastectomy
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
No
Xijing Hospital
Xi'an, Shaanxi, China
Start Date
July 1, 2015
Primary Completion Date
December 1, 2015
Completion Date
June 1, 2016
Last Updated
June 7, 2018
153
ACTUAL participants
transcutaneous electric acupoint stimulation
OTHER
electrode attached but no stimulation
OTHER
Lead Sponsor
Xijing Hospital
NCT04597372
NCT06430957
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06528288